FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc., typically reflecting updates to labeling or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation
• Irritable Bowel Syndrome with Constipation
• Opioid-induced Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

SUPPL AP for LUBIPROSTONE (LUBIPROSTONE)